Erik Sistermans is a Clinical Laboratory Geneticist, with both a national (VKGL) and a European (EBMG) registration. He is professor of Human Genetics and head of the Genome analysis laboratory of AmsterdamUMC, which involves the Genome Diagnostics laboratory, the NIPT screening laboratory and the Core Facility Genomics (CFG).

Erik Sistermans is professor at the dept. of Human Genetics, Amsterdam UMC. He is member of the research board of the Amsterdam Reproduction & Development research institute.

Research interests focus on the improvement of prenatal screening and diagnostics. Based on the results obtained with the Dutch TRIDENT studies (Trial by Dutch laboratories for Evaluation of Non-Invasive Prenatal Testing), we are investigating genetic factors involved in clinical problems that can occur during and after pregnancy, such as growth restriction, early fetal demise and preeclampsia. Another interest is widening the scope of NIPT, what is technologically feasible and how can this be implemented in a responsible way.

Areas of interest: Genome diagnostics, prenatal screening and diagnostics, bioinformatics.

Dr. Sistermans is board member of the Dutch non-invasive prenatal test (NIPT) Consortium and project leader of the TRIDENT studies. He is board member of the VKGL (Vereniging Klinisch Genetische Laboratoriumdiagnostiek), chair of the advisory board of Genomic Quality Assessment (GenQA) and associate editor of Extracellular Vesicles and Circulating Nucleic Acids (EVCNA).

He (co-)published over 135 international articles (H-index 45).